Status: Not yet recruiting
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
This is a single-center randomized phase 2 open-label clinical trial.
Participants needed: 40
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Virginia Commonwealth UniversityUpdated: Jul 17, 2026Locations: 1
Eligibility criteria
Age ≥18 years at time of enrollment [+10]
Prior use of hypomethylating agent and venetoclax in combination (Note, use of h... [+12]